Skip to main content
BiotoxtechCo.,Ltd. logo

BiotoxtechCo.,Ltd. — Investor Relations & Filings

Ticker · 086040 ISIN · KR7086040003 KO Professional, scientific and technical activities
Open in API
Filings indexed 172 across all filing types
Latest filing 2024-04-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 086040

About BiotoxtechCo.,Ltd.

http://eng.biotoxtech.com/

Biotoxtech Co., Ltd. is a non-clinical Contract Research Organization (CRO) that provides safety and efficacy evaluation services. The company offers a comprehensive suite of GLP-compliant studies, including general toxicity, carcinogenicity, reproductive and developmental toxicity, genotoxicity, immunotoxicity, and safety pharmacology. It also conducts efficacy evaluations and provides analytical research services such as pharmacokinetics (PK/TK/ADME) and bioanalysis. Biotoxtech serves a diverse clientele developing pharmaceuticals, biomedicines, cell and gene therapies, medical devices, chemicals, agrochemicals, cosmetics, and health functional foods.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including changes in board members (directors) and their respective shareholdings. This falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks significant ownership thresholds and changes in the reporting entity's share structure.
2024-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM). It details the outcomes of voting on agenda items such as financial statement approval, director and auditor appointments, and business purpose changes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Biotoxtech. It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a regulatory filing specifically announcing the submission of the audit report to the exchange (KRX), which is a standard requirement for public companies in Korea. According to the 'Menu vs Meal' rule, this is the official filing of the audit results rather than a general report publication announcement, and it fits the 'Audit Report / Information' category. FY 2023
2024-03-21 Korean
사업보고서 (2023.12)
Annual Report Classification · 1% confidence The document is a '사업보고서' (Business Report) for the 24th fiscal year (2023.01.01-2023.12.31) submitted to the Financial Services Commission and Korea Exchange. It contains comprehensive financial statements, management discussion and analysis, audit reports, and detailed corporate governance information. This structure corresponds to the standard Korean Annual Report filing, which is equivalent to the 10-K category. FY 2023
2024-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Biotoxtech. It contains the agenda for the 24th Annual General Meeting, including reports on internal accounting, audit, and business operations, as well as proposals for financial statement approval, board appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, etc.) as part of the meeting materials. This type of document is standard for proxy solicitation and shareholder information ahead of an AGM.
2024-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of Biotoxtech Co., Ltd., including the meeting date, agenda items, and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM.
2024-03-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.